Company Registration No. 7631998 (England and Wales)
Malpapharm Ltd
Unaudited accounts
for the year ended 31 October 2025
Malpapharm Ltd
Unaudited accounts
Contents
Malpapharm Ltd
Company Information
for the year ended 31 October 2025
Directors
Mr Malcolm Brown
Mr Max Doyle
Company Number
7631998 (England and Wales)
Registered Office
117 Atwood Road
Didsbury
Manchester
M20 6JW
Accountants
Rebecca Williams Accountants Limited
62 Derbyshire Road
Sale
M33 3EL
Malpapharm Ltd
Statement of financial position
as at 31 October 2025
Intangible assets
59,265
118,532
Tangible assets
288,569
264,509
Cash at bank and in hand
170,139
187,986
Creditors: amounts falling due within one year
(541,875)
(512,117)
Net current assets
333,394
371,007
Total assets less current liabilities
681,228
754,048
Creditors: amounts falling due after more than one year
(299,815)
(392,380)
Provisions for liabilities
Other provisions
-
(7,000)
Net assets
381,413
354,668
Called up share capital
2
2
Profit and loss account
381,411
354,666
Shareholders' funds
381,413
354,668
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 July 2026 and were signed on its behalf by
Mr Malcolm Brown
Director
Company Registration No. 7631998
Malpapharm Ltd
Notes to the Accounts
for the year ended 31 October 2025
Malpapharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 7631998. The registered office is 117 Atwood Road, Didsbury, Manchester, M20 6JW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention.
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5-20 years straight line
Fixtures & fittings
10 years straight line
Intangible fixed assets are included at cost less accumulated amortisation. Amortisation is charged on a straight line basis over 5 years.
4
Intangible fixed assets
Other
At 1 November 2024
296,333
At 31 October 2025
296,333
At 1 November 2024
177,801
Charge for the year
59,267
At 31 October 2025
237,068
At 31 October 2024
118,532
Malpapharm Ltd
Notes to the Accounts
for the year ended 31 October 2025
5
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At 1 November 2024
288,157
147,357
435,514
Additions
8,453
36,458
44,911
At 31 October 2025
296,610
183,815
480,425
At 1 November 2024
30,752
140,253
171,005
Charge for the year
19,316
1,535
20,851
At 31 October 2025
50,068
141,788
191,856
At 31 October 2025
246,542
42,027
288,569
At 31 October 2024
257,405
7,104
264,509
Amounts falling due within one year
Trade debtors
314,877
274,334
Other debtors
10,207
7,528
Amounts falling due after more than one year
Amounts due from group undertakings etc.
273,572
305,508
7
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
64,834
61,441
Trade creditors
365,047
379,446
Taxes and social security
98,564
49,027
Other creditors
1,697
1,093
Loans from directors
9,973
17,851
8
Creditors: amounts falling due after more than one year
2025
2024
Bank loans
299,815
392,380
Malpapharm Ltd
Notes to the Accounts
for the year ended 31 October 2025
9
Provisions for liabilities
£
The provision represents dilapidation costs that have now been agreed and paid during the year
Allotted, called up and fully paid:
197 Ordinary shares of £0.01 each
1.97
1.97
1 A Ordinary shares of £0.01 each
0.01
0.01
1 B Ordinary shares of £0.01 each
0.01
0.01
1 C Ordinary shares of £0.01 each
0.01
0.01
11
Operating lease commitments
2025
2024
At 31 October 2025 the company had the following future minimum lease payments under non-cancellable operating leases for each of the following periods:
Not later than one year
33,813
8,890
Later than one year and not later than five years
41,819
25,187
12
Transactions with related parties
Group Transactions
Malpapharm Holdings Limited owed Malpapharm Limited £273,572 at 31 October 2025 (2024: £305,508). No interest has been charged on this loan.
Directors Transactions
Total directors remuneration for the year was £69,851 (2024: £74,092)
At the year end, Max Doyle had loaned £9,973 to the company (maximum during the year of £15,144). The loan is unsecured, interest free and repayable on demand.
No other transactions with directors or persons connected with them require disclosure
Malpapharm Holdings Limited has a 90% shareholding in Malpapharm Limited
14
Average number of employees
During the year the average number of employees was 38 (2024: 34).